ABILYPHARMA SL
Company details
- Active NIF/CIF: Not available
-
Telephone: Not available
-
Date of last BORME entry: 29/12/2017
-
Sector: Comercio al por mayor y al por menor. Excepto reparación de vehículos de motor
-
Address: C/ PEÑA BEZA 19 - POLIGONO DE SILVOTA (LLANERA)
-
Website: Not available
-
Intracommunity VAT: Not available
Featured products:
More information on ABILYPHARMA SL
-
29/12/2017 | BORME act no.: 511416 | Register: ASTURIASCeses/Dimisiones -
29/12/2017 | BORME act no.: 511416 | Register: ASTURIASNombramientos
-
29/12/2017 | BORME act no.: 511416 | Register: ASTURIASOtros conceptos
-
22/08/2017 | BORME act no.: 342951 | Register: ASTURIASAmpliación de capital
-
22/08/2017 | BORME act no.: 342951 | Register: ASTURIASModificaciones estatutarias
-
08/06/2017 | BORME act no.: 237908 | Register: ASTURIASConstitución
-
08/06/2017 | BORME act no.: 237908 | Register: ASTURIASNombramientos
Other information
The CIF assigned to ABILYPHARMA SL is -, and its commercial status is active. The company carries out its operations within the CNAE 4646 - Comercio al por mayor de productos farmacéuticos. Likewise, its SIC code - identifies it.
ABILYPHARMA SL employs a team of Between 1 and 9 employees and records an annual turnover of less than 2 million euros. The entity is registered in the Mercantile Registry of Asturias and has 3 registration charges. The last announcement in Borme was published on 29/12/2017, while the most recent deposit of ordinary annual accounts is from the year -.
To access the contact information of ABILYPHARMA SL, such as the phone number, address, or website, visit the Company Data module.
If you require additional information about ABILYPHARMA SL, you can review one of our available financial reports, the Annual Accounts of the company, or verify its default incidents in the RAI delinquency file.
All the financial, commercial, and legal information we provide about ABILYPHARMA SL comes from official sources and is regularly updated.
Do you want to know more about ABILYPHARMA SL??
Find out more about this company by consulting these reports:
